FDA Approves UNLOXCYT™ Label Update, Enhancing Treatment for Advanced Skin Cancer The FDA has updated the label for UNLOXCYT™, an innovative treatment for advanced squamous cell carcinoma, showcasing improved outcomes based on long-term data.

FDA Approves UNLOXCYT™ Label Update, Enhancing Treatment for Advanced Skin Cancer #United_States #Princeton #UNLOXCYT #cosibelimab #squamous_cell